This article discusses a novel approach to simulate inhaled nicotine delivery through pulsed intravenous infusions. This model aims to replicate the nicotine absorption process experienced during smoking.
Such a model can be instrumental in advancing research on smoking cessation therapies and evaluating the impact of nicotine reduction policies, ultimately supporting public health efforts to reduce tobacco-related harm.